A detailed history of Welch Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Welch Group, LLC holds 1,592,222 shares of PFE stock, worth $42.6 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares
1,592,222
Previous 1,560,118 2.06%
Holding current value
$42.6 Million
Previous $43.7 Million 5.56%
% of portfolio
2.01%
Previous 2.1%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$27.7 - $31.39 $889,280 - $1.01 Million
32,104 Added 2.06%
1,592,222 $46.1 Million
Q2 2024

Jul 17, 2024

BUY
$25.26 - $29.6 $1.71 Million - $2 Million
67,511 Added 4.52%
1,560,118 $43.7 Million
Q1 2024

Apr 09, 2024

BUY
$25.89 - $29.73 $14.7 Million - $16.9 Million
568,302 Added 61.48%
1,492,607 $41.4 Million
Q4 2023

Jan 22, 2024

SELL
$26.13 - $33.94 $1.45 Million - $1.88 Million
-55,431 Reduced 5.66%
924,305 $26.6 Million
Q3 2023

Oct 18, 2023

BUY
$32.09 - $37.51 $979,290 - $1.14 Million
30,517 Added 3.21%
979,736 $32.5 Million
Q2 2023

Jul 18, 2023

BUY
$36.12 - $41.79 $1.83 Million - $2.12 Million
50,693 Added 5.64%
949,219 $34.8 Million
Q1 2023

Apr 13, 2023

BUY
$39.39 - $51.28 $1.85 Million - $2.41 Million
47,028 Added 5.52%
898,526 $36.7 Million
Q4 2022

Jan 27, 2023

BUY
$41.75 - $54.5 $691,922 - $903,228
16,573 Added 1.98%
851,498 $43.6 Million
Q3 2022

Oct 13, 2022

BUY
$43.76 - $53.42 $1.09 Million - $1.33 Million
24,915 Added 3.08%
834,925 $36.5 Million
Q2 2022

Jul 21, 2022

BUY
$46.53 - $55.17 $1.2 Million - $1.42 Million
25,747 Added 3.28%
810,010 $42.5 Million
Q1 2022

Apr 29, 2022

BUY
$45.75 - $56.69 $1.16 Million - $1.43 Million
25,293 Added 3.33%
784,263 $40.6 Million
Q4 2021

Jan 26, 2022

BUY
$41.32 - $61.25 $1.12 Million - $1.66 Million
27,094 Added 3.7%
758,970 $44.8 Million
Q3 2021

Nov 05, 2021

BUY
$39.25 - $50.42 $26.2 Million - $33.6 Million
666,477 Added 1019.09%
731,876 $31.5 Million
Q2 2021

Jul 21, 2021

BUY
$35.91 - $40.68 $8,223 - $9,315
229 Added 0.35%
65,399 $2.56 Million
Q1 2021

Apr 23, 2021

BUY
$33.49 - $37.77 $87,308 - $98,466
2,607 Added 4.17%
65,170 $2.36 Million
Q4 2020

Jan 25, 2021

BUY
$33.47 - $42.56 $126,215 - $160,493
3,771 Added 6.41%
62,563 $2.3 Million
Q3 2020

Oct 28, 2020

SELL
$31.75 - $37.25 $127 - $149
-4 Reduced 0.01%
58,792 $2.16 Million
Q2 2020

Jul 22, 2020

BUY
$30.12 - $36.54 $109,335 - $132,640
3,630 Added 6.58%
58,796 $1.92 Million
Q1 2020

Apr 28, 2020

SELL
$27.03 - $38.62 $5,622 - $8,032
-208 Reduced 0.38%
55,166 $1.8 Million
Q4 2019

Jan 24, 2020

BUY
$32.92 - $37.36 $16,361 - $18,567
497 Added 0.91%
55,374 $2.17 Million
Q3 2019

Nov 05, 2019

BUY
$32.49 - $42.13 $584 - $758
18 Added 0.03%
54,877 $1.97 Million
Q2 2019

Jul 11, 2019

SELL
$36.98 - $41.52 $157,054 - $176,335
-4,247 Reduced 7.19%
54,859 $2.38 Million
Q1 2019

Apr 15, 2019

BUY
$37.5 - $41.2 $112,425 - $123,517
2,998 Added 5.34%
59,106 $2.51 Million
Q4 2018

Jan 10, 2019

BUY
$38.47 - $43.86 $2,385 - $2,719
62 Added 0.11%
56,108 $2.45 Million
Q3 2018

Nov 01, 2018

BUY
$34.47 - $41.81 $20,440 - $24,793
593 Added 1.07%
56,046 $2.47 Million
Q2 2018

Jul 30, 2018

BUY
$32.98 - $35.16 $205,003 - $218,554
6,216 Added 12.62%
55,453 $2.01 Million
Q1 2018

Apr 23, 2018

SELL
$31.91 - $37.02 $17,167 - $19,916
-538 Reduced 1.08%
49,237 $1.75 Million
Q4 2017

Feb 01, 2018

BUY
$33.26 - $35.29 $1.4 Million - $1.49 Million
42,203 Added 557.36%
49,775 $1.8 Million
Q3 2017

Nov 07, 2017

SELL
$31.0 - $34.15 $599,881 - $660,836
-19,351 Reduced 71.88%
7,572 $270,000
Q2 2017

Aug 07, 2017

BUY
N/A
26,923
26,923 $904,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Welch Group, LLC Portfolio

Follow Welch Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch Group, LLC with notifications on news.